Advanced Biomed (ADVB) said Thursday it priced its initial public offering of 1.6 million shares at $4 per share, for expected gross proceeds of about $6.6 million.
The shares have been approved for listing on Nasdaq and are expected to start trading on Thursday under the ticker "ADVB," the company said.
Underwriters have been given a 45-day option to buy up to an additional 246,000 shares, Advanced Biomed said.
The offering is expected to close on or about Friday, it said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。